Market Flash on CBRL

Posted on Posted in insight

Cracker Barrel encountered recent challenges when the company faced swift and significant public backlash in August 2025 after unveiling a new, modernized logo. The simplified design was met with widespread criticism from customers, who viewed the change as a departure from the brand’s traditional, nostalgic image. In response to the latest news, we observed a rise in short interest, as EquiLend Borrow Quantity had increased by more than 1 million since mid-August and currently stands above 4.6 million shares. Social media amplified the negative sentiment, and the company’s stock price continued to decline.

Market Flash on CRCL

Posted on Posted in insight

EquiLend Data & Analytics presents a comparative analysis revealing critical lockup dynamics in securities lending markets. CoreWeave (CRWV) demonstrated extreme volatility around its accelerated lockup expiration on August 14, 2025, with borrowing costs peaking at 44,324 bps before collapsing. CRCL exhibits similar pre-lockup warning signals with utilization remaining elevated, suggesting potential for comparable volatility. Daily monitoring of borrowing metrics is essential to stay ahead of lockup-driven supply shocks.

Market Flash on KSS & OPEN

Posted on Posted in insight

Insight JULY 25, 2025 Market Flash Market Flash on Kohl’s (KSS) and Opendoor (OPEN) The Return of Meme Stock Mania Recent market activity has shown how heavily shorted stocks can be affected by coordinated retail trading campaigns. Our analysis of Kohl’s Corporation (KSS) and Opendoor Technologies (OPEN) identifies patterns in securities finance metrics that indicate […]

Market Flash on UNH

Posted on Posted in insight

UnitedHealth Group (TICKER: UNH) shares fell from $600 on April 11 to $275 as of May 15 erasing over $300 billion in market value as rising medical costs, regulatory pressures and a Department of Justice criminal investigation into possible Medicare fraud undermined investor confidence.

Market Flash on SMMT

Posted on Posted in insight

EquiLend Data & Analytics identifies Summit Therapeutics as a prime short squeeze candidate, with its squeeze score surging 43.0 points to 66 in just one month. With utilization approaching 78.98% and elevated borrow fees, short sellers are facing mounting pressure as positive clinical trial results drive momentum.

ORBISA ON MSTR

Posted on Posted in insight

Orbisa insights dives into MicroStrategy Incorporated (MSTR), which has seen a steady increase in demand in the securities lending market in recent months, with the total quantity of shares borrowed up 7% and the borrow demand percentage up 6% month over month.

Orbisa on NVIDIA

Posted on Posted in insight

In our latest analytical piece, Orbisa explores chipmaker Nvidia (NVDA), showing short sellers were active in Nvidia with the quantity of shares on loan increasing over the past year before peaking at 24 million shares in March; however, with Nvidia’s share price riding the tailwinds of the AI boom, borrowing demand for shares has collapsed.

ORBISA ON C3.AI

Posted on Posted in insight

Orbisa provides robust metrics and intelligence for the buy-side enabling market participants to validate their short positions. Throughout Q1, Orbisa insights show a sustained increase in Utilization and Short Interest for C3.AI following a rise in share price.